AgomAb director Epstein buys 5,000 shares
AgomAb Therapeutics NV director David R. Epstein reported a purchase of 5,000 shares at $8.90 each, for $44,500, in a Form 4 filed Oct. 8, 2026.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results.
AgomAb director Epstein buys 10,000 shares of AGMB
AgomAb Therapeutics NV director David R Epstein reported purchasing 10,000 shares of AGMB at $8.64 per share, for about $86,350, during Oct. 5–6, 2026.